Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.
Press releases published on May 22, 2025
Award-Winning Designer Maryna Karpenko Honored for Shaping Consumer and B2B Experiences at Meta, Mattermost, Hily, and Wavechat
GlobeNewswire
·
May 22, 2025
Award-winning product designer Maryna Karpenko is recognized for her leadership in shaping messaging and live-streaming experiences at Meta, Mattermost, Hily, and Wavechat. She has earned top industry honors for her work connecting millions of users …
KBR Announces Intent to Build Human Spaceflight Innovation Facility at ACMI Properties’ Exploration Park, Supporting Missions to Mars, the Moon, and In-Orbit
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- ACMI Properties (“ACMI”), a national industrial developer of mission-critical aerospace and national security facilities, today announced that KBR (NYSE: KBR), a global leader in human spaceflight and aerospace …
Global E-Commerce Market to Reach USD 21.22 Trillion by 2030, Says Mordor Intelligence
EIN Presswire
·
May 22, 2025
The e-commerce market is segmented by B2C (beauty …
IAOP Includes IBA Group in All Sub-Lists of The Global Outsourcing 100 for Sixth Straight Year
EIN Presswire
·
May 22, 2025
IAOP® released The 2025 Global Outsourcing 100® list and sub-lists. IBA Group earned recognition for Sustained Excellence and was named an All Star Company. PRAGUE, CZECH REPUBLIC, May 22, 2025 /EINPresswire.com/ -- The International Association of …
Helmet Mounted Display Market to Surge with 6.2% CAGR, Projected to Hit US$ 1,599.9 Million by 2035: Fact.MR Report
EIN Presswire
·
May 22, 2025
HMD market grows with rising demand for real-time awareness, hands-free use, and training tech across defense, aviation, and industry, says Fact.MR. ROCKVILLE, MD, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- According to Fact.MR, a market research …
إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي
EIN Presswire
·
May 22, 2025
إطلاق «مسار الغرير» لتعزيز فرص توظيف الشباب الإماراتي عبر الذكاء الاصطناعي، من خلال مسارات مخصّصة وتوصيات تدريبية وربط مباشر مع سوق العمل DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /EINPresswire.com/ -- 22 مايو 2025 – دبي، الإمارات العربية المتحدة: أطلقت …
New AI-Powered Platform Launched to Boost Emirati Youth Employment
EIN Presswire
·
May 22, 2025
AI platform Massar Al Ghurair launched to equip Emirati youth with personalized career pathways, future-ready skills, and job-matching tools through ethical AI. DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /EINPresswire.com/ -- The Abdulla Al Ghurair …
Actual SEO Media, Inc. Reveals Ways to Blend AI and Human Touch in Content Development
EIN Presswire
·
May 22, 2025
Actual SEO Media, Inc. encourages business owners to use AI and human skills. These tools can boost efficiency without sacrificing authenticity. HOUSTON, TX, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- Artificial intelligence (AI) has made …
Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
GlobeNewswire
·
May 22, 2025
REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Soleno’s Marketing Authorization …
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
GlobeNewswire
·
May 22, 2025
- 63% response rate observed among 43 evaluable patients - 79% overall survival rate at 12-months; 9 months median progression-free survival - Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
– Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm …
PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 22, 2025
Phase 2: Versamune® HPV with pembrolizumab as 1L treatment of r/m HPV16-positive HNSCC - Median overall survival for CPS ≥20 is 39.3 months - Median overall survival for CPS ≥1 is 30.0 months Phase 3: Versamune® HPV with pembrolizumab as 1L treatment of r/ …
Abcourt annonce ses résultats du troisième trimestre terminé le 31 mars 2025
GlobeNewswire
·
May 22, 2025
ROUYN-NORANDA, Québec, 22 mai 2025 (GLOBE NEWSWIRE) -- Mines Abcourt Inc. (« Abcourt » ou la « Société ») (TSX Venture: ABI) (OTCQB : ABMBF) annonce ses résultats du troisième trimestre terminé le 31 mars 2025. Toutes les valeurs monétaires dans ce …
Abcourt Announces its Results for the Third Quarter Ended March 31, 2025
GlobeNewswire
·
May 22, 2025
ROUYN-NORANDA, Quebec, May 22, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the third quarter ended March 31, 2025. All monetary values in this press release are …
IMUNON Announces Withdrawal of Form S-1 Registration Statement
GlobeNewswire
·
May 22, 2025
LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and …
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th
GlobeNewswire
·
May 22, 2025
BROOKINGS, S.D., May 22, 2025 (GLOBE NEWSWIRE) -- Daktronics, Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide today announced that Brad …
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
GlobeNewswire
·
May 22, 2025
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and venetoclax (Aza-Ven) achieves unprecedented high remission rates overall and across molecular subtypes in newly …
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
GlobeNewswire
·
May 22, 2025
CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b …